Erschienen in:
03.03.2020 | COVID-19 | What's New in Intensive Care
COVID-19: a novel coronavirus and a novel challenge for critical care
verfasst von:
Yaseen M. Arabi, Srinivas Murthy, Steve Webb
Erschienen in:
Intensive Care Medicine
|
Ausgabe 5/2020
Einloggen, um Zugang zu erhalten
Excerpt
In December 2019, several cases of pneumonia of unknown etiology were reported in Wuhan, Hubei Province, China, and were linked to Huanan Seafood Wholesale Market [
1‐
3]. The disease which is now called COVID-19 is caused by a novel coronavirus, labeled as SARS-CoV-2, which was discovered through whole-genome sequencing, polymerase chain reaction (PCR) and culture of bronchoalveolar lavage fluid obtained from affected patients [
1,
4]. This virus, which is the seventh coronavirus that has been proven to infect humans, has 75–80% genomic similarity to the severe acute respiratory syndrome coronavirus (SARS-CoV), 50% to the Middle East Respiratory syndrome coronavirus (MERS-CoV) and 96% to a bat coronavirus and uses the same cell receptor, angiotensin-converting enzyme II (ACE2), that is used by SARS-CoV [
1,
4,
5]. …